Roundtable Discussion: How Can Patient-Derived Cells and High- Throughput Models Advance Our Understanding of Skin Disease Heterogeneity?
Time: 1:00 pm
day: Day One PM
Details:
- Exploring the use of patient-derived cells to better model individual variability driven by genetics, microenvironment, and environmental triggers
- Using simple cell-based assays to screen therapeutic candidates before moving into more complex, tissue-like co-culture systems
- Investigating how inflammatory cytokines and molecular signals can be layered into co-cultures to mimic lesion-specific disease states
- Understanding the importance of recapitulating 3D skin architecture to accurately predict treatment efficacy in heterogeneous patient populations
